Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program

Tu HY, Wu YL

OncoTargets and Therapy 2020, 13:12539-12547

Published Date: 7 December 2020